CUTANEOUS MALACOPLAKIA

This adverse event was reported 27 times

These drugs are most commonly taken by patients reporting CUTANEOUS MALACOPLAKIA:

# Drug Count
0 TACROLIMUS 24
1 TACROLIMUS CAPSULES 21
2 MYCOPHENOLATE MOFETIL 16
3 PREDNISOLONE 11
4 PREDNISONE 10
5 METHYLPREDNISOLONE 9
6 MYCOPHENILIC ACID 7
7 MYCOPHENOLIC ACID 7
8 CYCLOSPORINE 2
9 AZATHIOPRINE 1
See all common drugs associated with CUTANEOUS MALACOPLAKIA

CUTANEOUS MALACOPLAKIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MYCOPHENILIC ACID 7 0.0008
1 MYCOPHENOLIC ACID 7 0.0004
2 TACROLIMUS CAPSULES 21 0.0003
3 TACROLIMUS 24 0.0002
4 MYCOPHENOLATE MOFETIL 16 0.0002
5 METHYLPREDNISOLONE 9 0.0001
6 PREDNISOLONE 11 0.0001
7 PREDNISONE 10 0.0000
8 CYCLOSPORINE 2 0.0000
9 AZATHIOPRINE 1 0.0000
See all drugs enriched for association with CUTANEOUS MALACOPLAKIA

These drug classes are most commonly taken by patients reporting CUTANEOUS MALACOPLAKIA:

# Drug class Count
0 Corticosteroid [EPC] 21
1 Antimetabolite Immunosuppressant [EPC] 7
2 Calcineurin Inhibitor Immunosuppressant [EPC] 2
3 Purine Antimetabolite [EPC] 1
See all common drug classes associated with CUTANEOUS MALACOPLAKIA

CUTANEOUS MALACOPLAKIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 7 0.0008
1 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
2 Corticosteroid [EPC] 21 0.0000
3 Purine Antimetabolite [EPC] 1 0.0000
See all drug classes enriched for association with CUTANEOUS MALACOPLAKIA